Keywords: \life sciences, financing, IPOs, M&A, Partnering, Pfizer, Zoetis, Allergan, MAP Pharma, Burrill & Co

Zoetis IPO caps strong month for life sciences financings, says Burrill & Co

Article | 04 February 2013

Print This

Life sciences financing activity got a strong start in the New Year as companies raised $10.3 billion in January. The Pfizer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in